SARS Coronavirus: Minireview

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F15%3A43907834" target="_blank" >RIV/62156489:43210/15:43907834 - isvavai.cz</a>
Result on the web
<a href="http://web2.mendelu.cz/af_239_nanotech/J_Met_Nano/0115/pdf/JMN1-2015-6.pdf" target="_blank" >http://web2.mendelu.cz/af_239_nanotech/J_Met_Nano/0115/pdf/JMN1-2015-6.pdf</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
SARS Coronavirus: Minireview
Original language description
The infection of SARS Coronavirus (CoV) was first observed in 2002. Since 2004, there have not been any new cases of this disease. However, new coronaviruses able to infect humans were found in bats and during the outbreak of Middle East Respiratory Syndrome Coronavirus. To effectively fight the coronavirus infections, the properties of SARS-CoV are still studied. In this review, we describe the genome, replication and transcription and important proteins of SARS--CoV. Also the ability of SARS-CoV to evade the innate immune system of host is described. The second part of this review discusses the methods for detection and treatment of SARS-CoV
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EE - Microbiology, virology
OECD FORD branch
—

Project
<a href="/en/project/GA14-18344S" target="_blank" >GA14-18344S: Development of nanoparticle-based cytostatics and enzymes for enhanced chemotherapy of human neuroblastomas and study of mechanisms of their action</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)